SCHEMBL29939144

SCHEMBL29939144

CC(C)C[C@H](NC(=O)[C@H](CCCNC(=N)N)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](Cc1ccc(O)cc1)NC(=O)[C@@H]1CCCN1C(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCCNC(=N)N)C(C)C)C(=O)N[C@@H](CS)C(=O)NCC(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](Cc1ccccc1)C(=O)O

nearest known ligand 0.61

Predicted protein targets (top 12)

geneUniProtsupporting neighboursconfidence
▸ NPY2R P49146 7/20 0.58
▸ NPY4R P50391 7/20 0.58
▸ NPY5R Q15761 7/20 0.58
▸ NPY1R P25929 5/20 0.58
▸ NMUR2 Q9GZQ4 4/20 0.58
▸ NMUR1 Q9HB89 4/20 0.58
▸ TFPI P10646 3/20 0.58
▸ RAMP3 O60896 3/20 0.57
▸ CALCR P30988 3/20 0.57
▸ MAPK8 P45983 1/20 0.57
▸ MAPK9 P45984 1/20 0.57
▸ MAPK10 P53779 1/20 0.57

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30218807 0.90 NPY2R (0.65) NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29711789 0.90 NPY2R (0.65) NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29632841 0.90 TFPI (0.64) NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL30432086 0.90 RAMP3 (0.63) NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL30824301 0.89 NPY2R (0.63) NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL29561936 0.89 NMUR2 (0.64) NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL30184264 0.88 TFPI (0.62) NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL29726735 0.88 EP300 (0.67) NPY2RNPY4RNPY5RNPY1RTFPI
SCHEMBL30432104 0.88 TFPI (0.69) NPY2RNPY4RNPY5RNPY1RNMUR2
SCHEMBL31182904 0.87 NMUR2 (0.65) NPY2RNPY4RNPY5RNPY1RNMUR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115066254-A Human anti-inflammatory peptides for inhalation treatment of inflammatory lung diseases 阿德维塔生命科学有限责任公司 2022-09-16 — — CN disclosed
Send feedback